Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.20% | 4.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.20% | 4.56% | |||
| Cost of Revenue | 0.48% | 1.83% | |||
| Gross Profit | -0.20% | 8.70% | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | 0.47% | 1.66% | |||
| Other Operating Expenses | 36.15% | -24.02% | |||
| Total Operating Expenses | 0.17% | 2.40% | |||
| Operating Income | 0.32% | 18.09% | |||
| Income Before Tax | 9.10% | 11.91% | |||
| Income Tax Expenses | 12.30% | 5.42% | |||
| Earnings from Continuing Operations | 8.24% | 13.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 13.31% | -16.98% | |||
| Net Income | 11.96% | 13.23% | |||
| EBIT | 0.32% | 18.09% | |||
| EBITDA | 0.35% | 13.84% | |||
| EPS Basic | 15.76% | 13.87% | |||
| Normalized Basic EPS | 6.11% | 23.64% | |||
| EPS Diluted | 14.52% | 15.42% | |||
| Normalized Diluted EPS | 5.04% | 25.16% | |||
| Average Basic Shares Outstanding | -3.28% | -0.57% | |||
| Average Diluted Shares Outstanding | -2.30% | -1.77% | |||
| Dividend Per Share | 9.09% | 0.00% | |||
| Payout Ratio | -0.03% | -0.14% | |||